These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10665328)

  • 1. Cardiac metabolism in ischemic heart disease.
    Opie LH
    Arch Mal Coeur Vaiss; 1999 Dec; 92(12):1755-60. PubMed ID: 10665328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucose-insulin-potassium (GIK) in prevention and therapy of myocardial ischemia].
    Haider W; Hiesmayr M
    Wien Klin Wochenschr; 2000 Apr; 112(7):310-21. PubMed ID: 10849955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Persistent" angina: rationale for a metabolic approach].
    Marzilli M
    Ital Heart J; 2004 Mar; 5 Suppl 2():37S-41S. PubMed ID: 15074776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic support of the ischemic heart during cardiac surgery].
    Luna Ortiz P; Serrano Valdés X; Rojas Pérez E; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S121-36. PubMed ID: 17469340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic intervention for the ischemic and post-ischemic heart.
    Svedjeholm R; Håkanson E; Szabó Z
    Wien Klin Wochenschr; 1999 Jul; 111(13):501-11. PubMed ID: 10444803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
    Lee L; Horowitz J; Frenneaux M
    Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs.
    Zhang HX; Zang YM; Huo JH; Liang SJ; Zhang HF; Wang YM; Fan Q; Guo WY; Wang HC; Gao F
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):306-13. PubMed ID: 17204910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model.
    Oates A; Nubani R; Smiley J; Kistler L; Hughey S; Theiss P; Perez-Tamayo RA; Eiferman D; Lonchyna V; Higgins RS
    Surgery; 2009 Jul; 146(1):23-30. PubMed ID: 19541007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Gans RO; de Boer MJ; Zijlstra F;
    Am Heart J; 2005 Apr; 149(4):585-91. PubMed ID: 15990738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, insulin, and potassium for metabolic support in acute myocardial infarction: is the jury still out?
    Broder HJ; Nesto RW
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S44-50. PubMed ID: 17224877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes.
    Szabó Z; Arnqvist H; Håkanson E; Jorfeldt L; Svedjeholm R
    Clin Sci (Lond); 2001 Jul; 101(1):37-43. PubMed ID: 11410112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac protection during acute myocardial infarction: where do we stand in 2004?
    Kloner RA; Rezkalla SH
    J Am Coll Cardiol; 2004 Jul; 44(2):276-86. PubMed ID: 15261919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
    Wang W; Lopaschuk GD
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1123-34. PubMed ID: 18035928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin in acute coronary syndromes].
    Halimi S
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():63-70. PubMed ID: 15666485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.
    Türel B; Gemici K; Baran I; Yeşilbursa D; Güllülü S; Aydinlar A; Serdar A; Kazazoğlu AR; Kumbay E; Cordan J
    Anadolu Kardiyol Derg; 2005 Jun; 5(2):90-4. PubMed ID: 15939681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucose-insulin-potassium (GIK) solution: cardioprotective effects of insulin].
    Rojas Pérez EM; Luna Ortiz P; Serrano Valdez X; Fernández Rivera BJ; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S144-51. PubMed ID: 17469342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacologic limitation of the size of the myocardial infarction (excluding thrombolysis)].
    Zannad F; Gilgenkrantz JM; Royer RJ
    Ann Cardiol Angeiol (Paris); 1985; 34(7):467-73. PubMed ID: 2865926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.